Recarbrio

Adult Dosing .

Dosage forms:  INJ

Special Note

[strength clarification]

Info: doses expressed as total imipenem + cilastatin + relebactam amt; 1.25 g imipenem/cilastatin/relebactam contains 0.5 g imipenem + 0.5 g cilastatin + 0.25 g relebactam

pneumonia, hospital-acquired or ventilator-assoc.

[1.25 g IV q6h x7 days]

Info: may extend duration based on clinical response; refer to IDSA guidelines

intra-abdominal infections, complicated

[1.25 g IV q6h x4-14 days]

Info: for pts w/ limited or no alternative tx options; duration varies w/ infection type, pathogen susceptibility

UTI, complicated

[1.25 g IV q6h x4-14 days]

Info: for pts w/ limited or no alternative tx options; duration varies w/ infection type, pathogen susceptibility

renal dosing

[see below]

CrCl 60-89: 1 g q6h; CrCl 30-59: 0.75 g q6h; CrCl 15-29: 0.5 g q6h; CrCl <15: avoid unless HD w/in 48h

HD: 0.5 g q6h, on dialysis days admin. after dialysis; consider supplement if next maint. dose not due right after dialysis; PD: not defined

hepatic dosing

[no adjustment]

Peds Dosing .

Peds dosing is currently unavailable or not applicable for this drug.